Quick Answer
NOVAVAX INC reported Total Assets of $1.18 billion for fiscal year 2025.
NOVAVAX INC Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.18B | -24.6% |
| 2024 | $1.56B | -13.2% |
| 2023 | $1.80B | -20.4% |
| 2022 | $2.26B | -12.3% |
| 2021 | $2.58B | +62.8% |
| 2020 | $1.58B | +815.0% |
| 2019 | $172.96M | -16.8% |
| 2018 | $207.98M | -31.2% |
| 2017 | $302.49M | -23.3% |
| 2016 | $394.30M | +2.1% |
| 2015 | $386.04M | +39.9% |
| 2014 | $276.00M | +17.4% |
| 2013 | $235.12M | +129.7% |
| 2012 | $102.34M | +53.7% |
| 2011 | $66.58M | -11.0% |
| 2010 | $74.84M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.18B | -31.1% | -11.7% |
| June 30, 2025 | $1.34B | -26.5% | +3.4% |
| March 31, 2025 | $1.29B | -4.5% | -17.1% |
| December 31, 2024 | $1.56B | -13.2% | -8.9% |
| September 30, 2024 | $1.71B | +3.3% | -5.8% |
| June 30, 2024 | $1.82B | +7.9% | +34.4% |
| March 31, 2024 | $1.35B | -12.3% | -24.7% |
| December 31, 2023 | $1.80B | -20.4% | +8.5% |
- NOVAVAX INC showed a decrease of -24.6% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, NOVAVAX INC’s total assets has grown by 1472.0% (from $74.84 million to $1.18 billion).
- The most recent figure is from NOVAVAX INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: